Lexology February 26, 2025
March 18 deadline for comments on state registration for telehealth controlled substances prescribing remains unchanged in newly released DEA and HHS rules
Overview
Less than a month after the Drug Enforcement Administration (DEA) and Department of Health and Human Services (HHS) published two final rules and one proposed rule regulating the remote prescribing of controlled substances via telemedicine, they have already announced changes. On February 19, the DEA and HHS decided to delay the effective date of the final rules from February 18 to March 21, due to the change in presidential administrations and President Donald Trump’s “Regulatory Freeze Memorandum.” The February 19 publication, however, does not affect other rules and proposals in this space that have been previously published,...
Today's Sponsors
Today's Sponsor